FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1383-1393 May 2, 2002 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

This affection of the bronchia is always produced by chronic catarrh, or by some other disease attended by long, violent, and often repeated fits of coughing.

R.T.H. Laënnec¹

Bronchiectasis is an uncommon disease with the potential to cause devastating illness, including repeated respiratory infections requiring antibiotics, disabling productive cough, shortness of breath, and occasional hemoptysis. Landmarks in the history of bronchiectasis include the vivid descriptions of patients with suppurative phlegm that appeared in the writings of René Théophile Hyacinthe Laënnec in the early 19th century; the 1922 introduction by Jean Athanase Sicard of contrast bronchography, which permitted the precise imaging . . . [Full Text of this Article]

Pathophysiology

Focal and Diffuse Presentations

Causes

Infections

Primary Ciliary Dyskinesia

Immunodeficiency

Cystic Fibrosis

Rheumatoid Arthritis

Inflammatory Bowel Disease

Symptoms and Physical Findings

Diagnostic Testing

Pulmonary Function

Management

Acute Exacerbations or Bronchitis

Prevention or Suppression of Microbes

Bronchopulmonary Hygiene

Surgery

Hemoptysis

Prognosis

Conclusion and Revised Definitions

Source Information

From the Pulmonary and Critical Care Division, Department of Medicine, Oregon Health and Science University, Portland.

Address reprint requests to Dr. Barker at the Pulmonary and Critical Care Division, Department of Medicine, Oregon Health and Science University, Portland, OR 97201, or at barkera@ohsu.edu.

References

This article has been cited by other articles:

• Loebinger, M. R., Wells, A. U., Hansell, D. M., Chinyanganya, N., Devaraj, A., Meister, M., Wilson, R. (2009). Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 34: 843-849 [Abstract] [Full Text]  
• Cantin, L., Bankier, A. A., Eisenberg, R. L. (2009). Bronchiectasis. Am. J. Roentgenol. 193: W158-W171 [Full Text]  
• Murray, M. P., Pentland, J. L., Turnbull, K., MacQuarrie, S., Hill, A. T. (2009). Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis. Eur Respir J 34: 361-364 [Abstract] [Full Text]  
• Gillham, M. I., Sundaram, S., Laughton, C. R., Haworth, C. S., Bilton, D., Foweraker, J. E. (2009). Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis. J Antimicrob Chemother 63: 728-732 [Abstract] [Full Text]  
• Burgel, P-R., Nadel, J. A. (2008). Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J 32: 1068-1081 [Abstract] [Full Text]  
• O'Donnell, A. E. (2008). Bronchiectasis. Chest 134: 815-823 [Abstract] [Full Text]  
• Loebinger, M., Shoemark, A, Berry, M, Kemp, M, Wilson, R (2008). Procalcitonin in stable and unstable patients with bronchiectasis. Chronic Respiratory Disease 5: 155-160 [Abstract]  
• Courtney, J., Kelly, M., Watt, A, Garske, L, Bradley, J, Ennis, M, Elborn, J. (2008). Quality of life and inflammation in exacerbations of bronchiectasis. Chronic Respiratory Disease 5: 161-168 [Abstract]  
• Hasani, A, Chapman, T., McCool, D, Smith, R., Dilworth, J., Agnew, J. (2008). Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis. Chronic Respiratory Disease 5: 81-86 [Abstract]  
• Fuschillo, S., De Felice, A., Balzano, G. (2008). Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur Respir J 31: 396-406 [Abstract] [Full Text]  
• Eren, S., Esme, H., Avci, A. (2007). Risk factors affecting outcome and morbidity in the surgical management of bronchiectasis. J. Thorac. Cardiovasc. Surg. 134: 392-398 [Abstract] [Full Text]  
• Goss, C. H, Burns, J. L (2007). Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis. Thorax 62: 360-367 [Abstract] [Full Text]  
• Koff, J. L., Shao, M. X. G., Kim, S., Ueki, I. F., Nadel, J. A. (2006). Pseudomonas Lipopolysaccharide Accelerates Wound Repair via Activation of a Novel Epithelial Cell Signaling Cascade. J. Immunol. 177: 8693-8700 [Abstract] [Full Text]  
• Wenzel, R. P., Fowler, A. A. III (2006). Acute Bronchitis. NEJM 355: 2125-2130 [Full Text]  
• Bilton, D., Henig, N., Morrissey, B., Gotfried, M. (2006). Addition of Inhaled Tobramycin to Ciprofloxacin for Acute Exacerbations of Pseudomonas aeruginosa Infection in Adult Bronchiectasis.. Chest 130: 1503-1510 [Abstract] [Full Text]  
• Ziedalski, T. M., Kao, P. N., Henig, N. R., Jacobs, S. S., Ruoss, S. J. (2006). Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.. Chest 130: 995-1002 [Abstract] [Full Text]  
• Santamaria, F., Montella, S., Camera, L., Palumbo, C., Greco, L., Boner, A. L. (2006). Lung structure abnormalities, but normal lung function in pediatric bronchiectasis.. Chest 130: 480-486 [Abstract] [Full Text]  
• Torrego, A, Haque, R A, Nguyen, L T, Hew, M, Carr, D H, Wilson, R, Chung, K F (2006). Capsaicin cough sensitivity in bronchiectasis. Thorax 61: 706-709 [Abstract] [Full Text]  
• Field, S. K., Cowie, R. L. (2006). Lung Disease Due to the More Common Nontuberculous Mycobacteria. Chest 129: 1653-1672 [Abstract] [Full Text]  
• Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., Johnston, S. L. (2006). Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations. Am. J. Respir. Crit. Care Med. 173: 1114-1121 [Abstract] [Full Text]  
• Koh, W-J, Kwon, O J, Wilson, R, Wickremasinghe, M, Ozerovitch, L J, Davies, G, Wodehouse, T, Chadwick, M V, Abdallah, S, Shah, P (2006). Bronchiectasis and non-tuberculous mycobacterial pulmonary infection * Authors' reply. Thorax 61: 458-458 [Full Text]  
• Rosen, M. J. (2006). Chronic Cough Due to Bronchiectasis: ACCP Evidence-Based Clinical Practice Guidelines. Chest 129: 122S-131S [Abstract] [Full Text]  
• Wickremasinghe, M, Ozerovitch, L J, Davies, G, Wodehouse, T, Chadwick, M V, Abdallah, S, Shah, P, Wilson, R (2005). Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 60: 1045-1051 [Abstract] [Full Text]  
• Scheinberg, P., Shore, E., on behalf of the PC-TNDS-008 Study Group, (2005). A Pilot Study of the Safety and Efficacy of Tobramycin Solution for Inhalation in Patients With Severe Bronchiectasis. Chest 127: 1420-1426 [Abstract] [Full Text]  
• Koh, W.-J., Lee, K. S., Kwon, O J., Jeong, Y. J., Kwak, S.-H., Kim, T. S. (2005). Bilateral Bronchiectasis and Bronchiolitis at Thin-Section CT: Diagnostic Implications in Nontuberculous Mycobacterial Pulmonary Infection. Radiology 235: 282-288 [Abstract] [Full Text]  
• van Kessel, D. A., van Velzen-Blad, H., van den Bosch, J. M. M., Rijkers, G. T. (2005). Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology. Eur Respir J 25: 482-489 [Abstract] [Full Text]  
• Tsang, K W, Tan, K C, Ho, P L, Ooi, G C, Ho, J C, Mak, J, Tipoe, G L, Ko, C, Yan, C, Lam, W K, Chan-Yeung, M (2005). Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 60: 239-243 [Abstract] [Full Text]  
• Field, S. K., Fisher, D., Cowie, R. L. (2004). Mycobacterium avium complex Pulmonary Disease in Patients Without HIV Infection. Chest 126: 566-581 [Abstract] [Full Text]  
• Patterson, J E, Bradley, J M, Elbom, J S (2004). Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques (incorporating postural drainage and vibration) versus test of incremental respiratory endurance. Chronic Respiratory Disease 1: 127-130 [Abstract]  
• Dupont, M., Gacouin, A., Lena, H., Lavoue, S., Brinchault, G., Delaval, P., Thomas, R. (2004). Survival of Patients With Bronchiectasis After the First ICU Stay for Respiratory Failure. Chest 125: 1815-1820 [Abstract] [Full Text]  
• Wolfgang, M. C., Jyot, J., Goodman, A. L., Ramphal, R., Lory, S. (2004). Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 101: 6664-6668 [Abstract] [Full Text]  
• Gibson, R. L., Burns, J. L., Ramsey, B. W. (2003). Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis. Am. J. Respir. Crit. Care Med. 168: 918-951 [Abstract] [Full Text]  
• Field, S. K., Cowie, R. L. (2003). Treatment of Mycobacterium avium-intracellulare complex Lung Disease With a Macrolide, Ethambutol, and Clofazimine. Chest 124: 1482-1486 [Abstract] [Full Text]  
• Murphy, T. F. (2003). Immunity to Nontypeable Haemophilus influenzae: Elucidating Protective Responses. Am. J. Respir. Crit. Care Med. 167: 486-487 [Full Text]  
• King, P. T., Hutchinson, P. E., Johnson, P. D., Holmes, P. W., Freezer, N. J., Holdsworth, S. R. (2003). Adaptive Immunity to Nontypeable Haemophilus influenzae. Am. J. Respir. Crit. Care Med. 167: 587-592 [Abstract] [Full Text]  
• Ryu, J. H., Olson, E. J., Midthun, D. E., Swensen, S. J. (2002). Diagnostic Approach to the Patient With Diffuse Lung Disease. Mayo Clin Proc. 77: 1221-1227 [Abstract]